Narrow search
Showing 1 - 10 of 867
Cover Image
Science-based Firms Going Public : the role of patent indicators and top management teams
Quintana García, Cristina; Benavides Velasco, Carlos A.; … - In: Industry and innovation 23 (2016) 3, pp. 243-259
Persistent link: https://www.econbiz.de/10011523871
Cover Image
Börsengänge englischer Fußballklubs - Implikationen für den sportlichen und wirtschaftlichen Wettbewerb und für die deutsche Bundesliga
Kipker, Ingo - In: Finanzierung des Sports : Beiträge des 2. Kölner …, (pp. 131-146). 2002
Persistent link: https://www.econbiz.de/10001656131
Cover Image
Positive and negative synergies between the CEO's and the corporate board's human and social capital : a study of biotechnology firms
Sundaramurthy, Chamu; Pukthuanthong, Kuntara; Kor, Yasemin - In: Strategic management journal 35 (2014) 6, pp. 845-868
Persistent link: https://www.econbiz.de/10010370336
Cover Image
Impact of initial seeds on the growth of biotechnology startups : evidence from the U.S. and Japan
Nishimura, Junichi; Tsai, Yungyun; Nagaoka, Sadao - In: Economics of innovation and new technology 28 (2019) 7, pp. 695-721
Persistent link: https://www.econbiz.de/10012200237
Cover Image
The role of strategic alliances in VC exits : evidence from the biotechnology industry
Brinster, Leonhard; Hopp, Christian; Tykvová, Tereza - In: Venture capital : an international journal of … 22 (2020) 3, pp. 281-313
Persistent link: https://www.econbiz.de/10012313469
Cover Image
Initial public offering and financing of biotechnology start-ups : evidence from Japan
Honjō, Yūji; Nagaoka, Sadao - 2015
Persistent link: https://www.econbiz.de/10011349852
Cover Image
Impacts of Intangible Assets on the Initial Public Offering of Biotechnology Startups
Fukugawa, Nobuya - 2013
This study examined how intangible assets of Japanese biotechnology startups affected their intention to go public at …
Persistent link: https://www.econbiz.de/10013091541
Cover Image
Financing Development Stage Biotechnology Companies : Reverse Mergers vs. IPOs
Ahn, Mark J. - 2014
We examine reverse mergers (RMs) in the biotechnology industry and find that, when compared to initial public offerings … capital intensive, high-risk biotechnology companies which require accessing deeper and larger pools of investors in public …
Persistent link: https://www.econbiz.de/10013067429
Cover Image
The Biotechnology Cluster in San Diego : An Analysis of IPO Activity and Probability of Success for Firms
Munteanu, Radu - 2014
The biotech cluster in San Diego is dominated by small firms, with approximately 73% of the firms employing between 1 to 49 employees. Among the main important sources of financing for the biotech companies are venture capital and initial public offerings. In spite of the aggregate increase in...
Persistent link: https://www.econbiz.de/10013070265
Cover Image
Leaving Money on the Table in Venture-Backed Biotechnology IPOs
Jeppsson, Hans - 2018
This study analyzes first-day returns (underpricing) for venture-backed biotechnology IPOs during 1980 through 2015 …-backed biotechnology IPOs with the largest amount of money left on the table in the history of biotechnology went public during 2014 …-2000, rational investors should at least be a little bit concerned about the state of the biotechnology equity market. From a …
Persistent link: https://www.econbiz.de/10012919021